Cargando…

Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD

A repeat expansion in the non-coding region of C9orf72 gene is the most common mutation causing frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Sense and antisense transcripts are translated into aggregating dipeptide repeat (DPR) proteins in all reading frames (pol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khosravi, Bahram, Hartmann, Hannelore, May, Stephanie, Möhl, Christoph, Ederle, Helena, Michaelsen, Meike, Schludi, Martin H., Dormann, Dorothee, Edbauer, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409121/ https://www.ncbi.nlm.nih.gov/pubmed/28040728 http://dx.doi.org/10.1093/hmg/ddw432

Ejemplares similares

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
por: Pickles, Sarah, et al.
Publicado: (2022)

Antibodies inhibit transmission and aggregation of C9orf72 poly‐GA dipeptide repeat proteins
por: Zhou, Qihui, et al.
Publicado: (2017)

Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
por: Schludi, Martin H, et al.
Publicado: (2017)

C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration
por: May, Stephanie, et al.
Publicado: (2014)

Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
por: Zhou, Qihui, et al.
Publicado: (2019)

Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
por: Gruijs da Silva, Lara A, et al.
Publicado: (2022)

C9orf72 dipeptides disrupt the nucleocytoplasmic transport machinery and cause TDP-43 mislocalisation to the cytoplasm
por: Ryan, Sarah, et al.
Publicado: (2022)

Cell‐to‐cell transmission of C9orf72 poly‐(Gly‐Ala) triggers key features of ALS/FTD
por: Khosravi, Bahram, et al.
Publicado: (2020)

Towards a TDP-43-Based Biomarker for ALS and FTLD
por: Feneberg, Emily, et al.
Publicado: (2018)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
por: Berning, Britt A., et al.
Publicado: (2019)

Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity
por: Hartmann, Hannelore, et al.
Publicado: (2018)

TDP‐43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons
por: Schwenk, Benjamin M, et al.
Publicado: (2016)

Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
por: Neumann, Manuela, et al.
Publicado: (2020)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
por: Fiondella, Luigi, et al.
Publicado: (2023)

TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
por: Arseni, Diana, et al.
Publicado: (2023)

Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS
por: Chang, Cheng-Fu, et al.
Publicado: (2016)

Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
por: Tamaki, Yoshitaka, et al.
Publicado: (2022)

Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALS C9orf72 Expansion Cases
por: Porta, Sílvia, et al.
Publicado: (2015)

TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration
por: Lee, Samuel M, et al.
Publicado: (2019)

Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1
por: Ederle, Helena, et al.
Publicado: (2018)

The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS
por: Dafinca, Ruxandra, et al.
Publicado: (2021)

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43
por: Tan, Rachel H, et al.
Publicado: (2013)

Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders
por: Janssens, Jonathan, et al.
Publicado: (2013)

Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
por: Wood, Alistair, et al.
Publicado: (2021)

NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
por: Gleixner, Amanda M., et al.
Publicado: (2022)

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
por: Yusuff, Tanzeen, et al.
Publicado: (2023)

C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
por: Josephs, Keith A., et al.
Publicado: (2019)

Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
por: Budini, Mauricio, et al.
Publicado: (2017)

Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A (GRN) vs Type B (C9orf72)
por: Cracco, Laura, et al.
Publicado: (2022)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
por: Koga, Shunsuke, et al.
Publicado: (2023)

Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss
por: Schludi, Martin H., et al.
Publicado: (2017)

The porphyrin TMPyP4 inhibits elongation during the noncanonical translation of the FTLD/ALS-associated GGGGCC repeat in the C9orf72 gene
por: Mori, Kohji, et al.
Publicado: (2021)

Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients
por: Prudencio, Mercedes, et al.
Publicado: (2017)

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP
por: Ferrer, Isidro, et al.
Publicado: (2021)

Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD
por: Ward, Michael E., et al.
Publicado: (2014)

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
por: Pottier, Cyril, et al.
Publicado: (2021)

Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
por: Riemenschneider, Henrick, et al.
Publicado: (2023)

Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
por: Koga, Shunsuke, et al.
Publicado: (2023)

White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations
por: Ameur, Fatima, et al.
Publicado: (2016)

A small deletion in C9orf72 hides a proportion of expansion carriers in FTLD
por: Rollinson, Sara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_houdoccvtl80vq65p8m7kk422n